Enhancement of DNA vaccine potency through linkage of antigen gene to ER chaperone molecules, ER-60, tapasin, and calnexin

Journal of Biomedical Science

Volumn 12, Issue 2, 2005, Pages 279-287

  Lin, Cheng Tao ^a   Chang, Ting Chang ^a   Chao, Angel ^a   Dzeng, Elizabeth ^b   Soong, Yung Kuei ^a   Hung, Chien Fu ^b   Lai, Chyong Huey ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calnexin; DNA vaccines; E7; ER 60; Human papillomavirus (HPV); Immunotherapy; Tapasin

Indexed keywords

ANTINEOPLASTIC AGENT; CALNEXIN; CANCER VACCINE; CHAPERONE; DNA VACCINE; IOXAGLIC ACID; PROTEIN E7; TAPASIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG POTENCY; ENDOPLASMIC RETICULUM; FEMALE; FREQUENCY ANALYSIS; GENETIC CODE; GENETIC LINKAGE; HUMAN PAPILLOMAVIRUS TYPE 16; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 21344450786     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-0334-y     Document Type: Article

References (41)

1. J.J. Donnelly J.B. Ulmer J.W. Shiver M.A. Liu 1997 DNA vaccines. Annu. Rev. Immunol. 15 617 648
2. S. Gurunathan D.M. Klinman R.A. Seder 2000 DNA vaccines: immunology, application, and optimization Annu. Rev. Immunol. 18 927 974
3. W.W. Leitner H. Ying N.P. Restifo 1999 DNA RNA-based vaccines: principles, progress and prospects Vaccine 18 765 777
4. H.L. Robinson 1997 Nucleic acid vaccines: an overview Vaccine 15 785 787
5. D.M Pardoll A.M Beckerleg 1995 Exposing the immunology of naked DNA vaccines. Immunity 3 165 169
6. F. Rodriguez L.L. An S. Harkins J. Zhang M. Yokoyama G. Widera J.T. Fuller C. Kincade I.L. Campbell J.L. Whitton 1998 DNA immunization with minigenes low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination J. Virol. 72 5174 5181
7. T.W. Tobery R.F. Siliciano 1997 Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp Med. 909-920 185
8. J.S. Boyle J.L Brady A.M. Lew 1998 Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 408-411 392
9. W.F. Cheng C.F. Hung C.Y. Chai K.F. Hsu L. He M. Ling T.C. Wu 2001 Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J. Clin Invest. 669-678 108
10. C.-F. Hung K.-F. Hsu W.-F. Cheng C.-Y. Chai L. He M. Ling T.-C. Wu 2001 Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Flt3-ligand Cancer Res. 1080-1088 61
11. A. Biragyn K. Tani M.C. Grimm S. Weeks L.W. Kwak 1999 Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity [see comments] Nat. Biotechnol. 253-258 17
12. C.-F. Hung W.-F. Cheng K.-F. Hsu C.-Y. Chai L. He M. Ling T.-C. Wu 2001 Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen Cancer Res. 3698-3703 61
13. CA King MB Spellerberg D Zhu J Rice SS Sahota AR Thompsett TJ Hamblin J. Radl FK Stevenson 1998 DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma [see comments] Nat. Med. 4 1281 1286
14. YH Chow BL Chiang YL Lee WK Chi WC Lin YT Chen MH Tao 1998 Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes J. Immunol. 160 1320 1329
15. WR Weiss KJ Ishii RC Hedstrom M Sedegah M Ichino K Barnhart DM Klinman SL Hoffman 1998 A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine J. Immunol. 161 2325 2332
16. M Corr H Tighe D Lee J Dudler M Trieu DC Brinson DA Carson 1997 Costimulation provided by DNA immunization enhances antitumor immunity J. Immunol. 159 4999 5004
17. DM Klinman G Yamshchikov Y Ishigatsubo 1997 Contribution of CpG motifs to the immunogenicity of DNA vaccines J. Immunol. 158 3635 3639
18. C Condon SC Watkins CM Celluzzi K Thompson LD Falo 1996 DNA-based immunization by in vivo transfection of dendritic cells Nat. Med. 2 1122 1128
19. A Porgador KR Irvine A Iwasaki B.H. Barber N.P. Restifo R.N. Germain 1998 Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization J. Exp. Med. 188 1075 1082
20. C.F. Hung T.C. Wu 2003 Improving DNA vaccine potency via modification of professional antigen presenting cells Curr. Opin. Mol. Ther. 5 20 24
21. P.J. Lehner J. Trowsdale 1998 Antigen presentation: coming out gracefully. Curr. Biol. R605-R608 8
22. Y. Wang D. Chen M.J. Androlewicz 1999 The role of endoplasmic reticulum-associated protein degradation in MHC class I antigen processing Immunol. Rev. 172 67 72
23. P.J. Lehner M.J. Surman P. Cresswell 1998 Soluble tapasin restores MHC Class 1 expression and function in the tapasin-negative cell line 220. Immunity 8 221 231
24. S. Li K.M. Paulsson H.-O. Sjögrn P. Wang 1999 Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing J. Biol. Chem. 274 8649 8654
25. B. Ortmann J. Copeman P. Lehner B. Sadasivan J. Herberg A.G. Grandea S.R. Riddell R. Tampe T. Spies J. Trowsdale 1997 A critical role for tapasin in the assembly and function of multimeric MHC Class 1â€"TAP complexes Science 277 1306 1309
26. C.A. Peh N. Laham S.R. Burrows Y. Zhu J. McCluskey 2000 Distinct functions of tapasin revealed by polymorphism in MHC class I peptide loading J. Immunol. 64 292 299
27. P. Spee J. Subjeck J. Neefjes 1999 Identification of novel peptide binding proteins in the endoplasmic reticulum: ERp72, calnexin, and grp170 Biochemistry 38 10559 10566
28. D.B. Williams 1995 Calnexin: a molecular chaperone with a taste for carbohydrate Biochem. Cell Biol. 73 123 132
29. J.A. Lindquist O.N. Jensen M. Mann G. HÃCurrency signmmerling 1998 ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class 1 assembly EMBO J. 17 2186 2195
30. E.A. Hughes P. Cresswell 1998 The thiol oxidoreductase ERp57 is a component of the MHC class 1 peptide-loading complex Curr. Biol. 8 709 712
31. J.D. Oliver H.L. Roderick D.H. Llewellyn S. High 1999 ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin Mol. Biol. Cell 10 2573 2582
32. L.H. Ellenson T.C. Wu 2004 Focus on endometrial and cervical cancer Cancer Cell 5 533 538
33. C.-H. Chen T.-L. Wang C.-F. Hung Y. Yang R.A. Young D.M. Pardoll T.-C. Wu 2000 Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene Cancer Res. 60 1035 1042
34. K.-Y. Lin F.G. Guarnieri K.F. Staveley-O'Carroll H.I. Levitsky T. August D.M. Pardoll T.-C. Wu 1996 Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen Cancer Res. 56 21 26
35. M.C. Feltkamp H.L. Smits M.P. Vierboom R.P. Minnaar B.M. de Jough J.W. Drijfhout J. ter Schegget C.J. Melief W.M. Kast 1993 Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells Eur. J. Immunol. 23 2242 2249
36. R.W. Tindle G.J. Fernando J.C. Sterling I.H. Frazer 1991 A 'public' T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes Proc. Natl. Acad. Sci. USA 88 5887 5891
37. C.J. Melief W.M. Kast 1995 T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes Immunol. Rev. 145 167 177
38. N.P. Restifo I. Bacik K.R. Irvine J.W. Yewdell B.J. McCabe R.W. Anderson L.C. Eisenlohr S.A. Rosenberg J.R. Bennink 1995 Antigen processing in vivo and the elicitation of primary CTL responses J. Immunol. 154 4414 4422
39. H. Ji T.-L. Wang C.-H. Chen C.-F. Hung S. Pai K.-Y. Lin R.J. Kurman D.M. Pardoll T.-C. Wu 1999 Targeting HPV-16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine HPV-16 E7-expressing tumors Human Gene Ther. 10 2727 2740
40. W.W. Nichols B.J. Ledwith S.V. Manam P.J. Troilo 1995 Potential DNA vaccine integration into host cell genome Ann. NY Acad. Sci. 772 30 39
41. D.V. Heck C.L. Yee P.M. Howley K. Munger 1992 Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses Proc. Natl. Acad. Sci. USA 89 4442 4446